Program

769
533
98
85
83
35
26
15
15
11
10
10
9
4
2

Journal Year Published

28
88
169
317
325
375
117
61
47
47
34
17
8
4
4
3
2
2
2
2

Author

165
164
120
117
114
110
105
105
104
77
72
71
61
52
50
41
39
37
33
31

Category

314
306
283
95
85
67
21
18
15
14
3
2

Keyword

1185
579
526
359
331
294
206
180
158
143
121
113
108
105
96
94
90
80
79
76

Journal

46
45
41
28
25
21
18
17
15
14
14
13
13
13
13
13
12
12
11
11

NCATS Publications

Literature Search and Review.


Simeonov A, Auld D


Assay Drug Dev Technol , (15), 307-313, .

Article Pubmed

Sample image from publication page

Computational drug repositioning for rare diseases in the era of precision medicine.


Delavan B, Roberts R, Huang R, Bao W, Tong W, Liu Z


Drug Discov. Today , (23), 382-394, 2018.

Article Pubmed

Sample image from publication page

Voluntary Site Accreditation - Improving the Execution of Multicenter Clinical Trials.


Johnston SC, Austin C, Lewis-Hall F


N. Engl. J. Med. , (377), 1414-1415, 2017.

Article Pubmed

Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.


Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, Karakousi TR, Ellis DC, Bhutkar A, Sánchez-Rivera FJ, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, Thomas C, Goparaju C, Davies A, Dolgalev I, Heguy A, Allaj V, Poirier JT, Moreira AL, Rudin CM, Pass HI, Vander Heiden MG, Jacks T, Papagiannakopoulos T


Nat. Med. , (23), 1362-1368, 2017.

Article Pubmed

Sample image from publication page

Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer.


Sayin VI, LeBoeuf SE, Singh SX, Davidson SM, Biancur D, Guzelhan BS, Alvarez SW, Wu WL, Karakousi TR, Zavitsanou AM, Ubriaco J, Muir A, Karagiannis D, Morris P, Thomas C, Possemato R, Vander Heiden MG, Papagiannakopoulos T


Elife , (6), 2017.

Article Pubmed

Sample image from publication page